WallStreetZenWallStreetZen

NASDAQ: LENZ
Lenz Therapeutics Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

LENZ earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$124.7M
Current Profit Margin
0%

LENZ Return on Equity

Current Company
-56.2%
Current Industry
-63.5%
Current Market
188%
LENZ's Return on Equity (-56.2%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when LENZ announces earnings.

LENZ Return on Assets

Current Company
-47.4%
Current Industry
2.9%
LENZ is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

LENZ Return on Capital Employed

Current Company
-67.87%
Current Industry
19.5%
LENZ's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

LENZ vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
LENZ$0.00-$117.96M-$124.65MN/AN/A
MCRB$126.33M-$85.43M-$113.72M+34.91%N/A
ELYM$0.00-$34.71M-$35.12MN/AN/A
SGMT$2.00M-$27.74M-$27.88MN/AN/A
RPTX$51.13M-$99.03M-$93.80M+722.89%N/A
View Top Biotech Stocks

LENZ earnings dates

Next earnings date
May 9, 2024

Lenz Therapeutics Earnings & Revenue FAQ

What were LENZ's earnings last quarter?

On Invalid Date, Lenz Therapeutics (NASDAQ: LENZ) reported Q4 2023 earnings per share (EPS) of -$2.80, up 9.09% year over year. Total Lenz Therapeutics earnings for the quarter were -$22.92 million. In the same quarter last year, Lenz Therapeutics's earnings per share (EPS) was -$3.08.

If you're new to stock investing, here's how to buy Lenz Therapeutics stock.

What was LENZ's earnings growth in the past year?

As of Q2 2024, Lenz Therapeutics's earnings has grown year over year. Lenz Therapeutics's earnings in the past year totalled -$124.65 million.

What is LENZ's earnings date?

Lenz Therapeutics's earnings date is Invalid Date. Add LENZ to your watchlist to be reminded of LENZ's next earnings announcement.

What was LENZ's revenue last quarter?

On Invalid Date, Lenz Therapeutics (NASDAQ: LENZ) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Lenz Therapeutics's revenue was $0.00.

What was LENZ's revenue growth in the past year?

As of Q2 2024, Lenz Therapeutics's revenue has grown null year over year. Lenz Therapeutics's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.